肺癌患者就醫延遲影響因素及干預措施研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

江淀淀 ¹ ,  崔妙玲 ² , 李惠顏 ³ , 陳泉芳 ¹

1. ;
2. ;
3. ;

Corresponding?author：

崔妙玲, Email: cuimiaoling@126.com

Keywords：

DOI：

10.7507/1671-6205.202302057

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 江淀淀, 崔妙玲, 李惠顏, 陳泉芳. 肺癌患者就醫延遲影響因素及干預措施研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2023, 22(6): 452-456. doi: 10.7507/1671-6205.202302057 Copy

1.	Shankar A, Saini D, Dubey A, et al. Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward. Transl Lung Cancer Res, 2019, 8(Suppl 1): S106-S121.
2.	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
3.	Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ, 2020, 4(371): m4087.
4.	繆愛云. 我國癌癥病人就醫延遲現狀研究的文獻分析. 循證護理, 2021, 7(3): 382-385.
5.	余柳瑩. 350例肺癌患者首發癥狀與就診延遲相關性分析. 中國醫藥科學, 2021, 11(2): 187 -190.
6.	Albano D, Bilfinger T, Feraca M, et al. A multidisciplinary lung cancer program: does it reduce delay between diagnosis and treatment? Lung, 2020, 198(6): 967-972.
7.	Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Thorac Oncol, 2016, 11(1): 39-51.
8.	Borges M, Gouveia M, Alarc?o J, et al. Cost and burden of non-small cell lung cancer’s in Portugal. Value Health, 2014, 17(7): A626.
9.	林璜, William W. Au, 歐利民. 癌癥延遲就醫研究. 中國腫瘤, 2016, 25(9): 667-671.
10.	Koo MM, Zhou Y, Lyratzopoulos G. Delays in diagnosis and treatment of lung cancer: Lessons from US healthcare settings. Cancer Epidemiol, 2015, 39(11): 45-47.
11.	Vinas F, Ben Hassen I, Jabot L, et al. Delays for diagnosis and treatment of lung cancers: a systematic review. Clin Respir J, 2016, 10(2): 67-71.
12.	González-Barcala FJ, García-Prim JM, Alvarez-Doba?o JM, et al. Effect of delays on survival in patients with lung cancer. Clin Transl Oncol, 2010, 12(8): 36-42.
13.	Lubuzo B, Ginindza T, Hlongwana K. The barriers to initiating lung cancer care in low-and middle-income countries. Pan Afr Med J, 2020, 12: 35-38.
14.	鄒浩, 姜東旭, 張琳琳. 慢性病患者就醫延遲評估工具及影響因素的研究進展. 中國全科醫學, 2022, 25(7): 893-898.
15.	Li PW, Lee DT, Yu DS. Psychometric evaluation of the perceived barriers to health care-seeking decision in Chinese patients with acute coronary syndromes. Heart Lung, 2014, 43(2): 140-145.
16.	楊柳青, 郝志紅. Fischer就醫態度量表的漢化及信效度分析. 中華行為醫學與腦科學雜志, 2020, 29(8): 757-762.
17.	王蕊琪, 賈紅紅, 周郁秋. 糖尿病診治延誤認知行為意向量表的開發與驗證. 中國全科醫學, 2021, 24(18): 2342-2348, 2358.
18.	趙秋利, 吳燕妮. 缺血性卒中高危者院前延遲行為意向測評量表的編制與驗證. 中國全科醫學, 2012, 15(32): 3703-3706, 3709.
19.	Lubuzo B, Ginindza T, Hlongwana K. Exploring barriers to lung cancer patient access, diagnosis, referral and treatment in Kwazulu-Natal, South Africa: the health providers' perspectives. Transl Lung Cancer Res, 2019, 8(4): 380-391.
20.	Mapanga W, Norris SA, Chen WC, et al. Consensus study on the health system and patient-related barriers for lung cancer management in South Africa. PLoS One, 2021, 16(2): e0246716.
21.	Malalasekera A, Dhillon HM, Shunmugasundaram C, et al. Why do delays to diagnosis and treatment of lung cancer occur? A mixed methods study of insights from Australian clinicians. Asia Pac J Clin Oncol, 2021, 17(2): e77-e86.
22.	van Os S, Syversen A, Whitaker KL, et al. Lung cancer symptom appraisal, help-seeking and diagnosis-rapid systematic review of differences between patients with and without a smoking history. Psychooncology, 2022, 31(4): 562-576.
23.	陳慶馀. 臺灣家庭醫學的發展與挑戰. 中國全科醫學, 2016, 19(4): 375-377.
24.	Amadori D, Serra P, Bucchi L, et al. The mwanza cancer project. Lancet Oncol, 2016, 17(2): 146-148.
25.	Barata F, Fidalgo P, Figueiredo S, et al. Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis. PLoS One, 2021, 16(6): e0252529.
26.	周敏, 許震娟. 慢阻肺急性加重期患者延遲就醫與家庭動力學的相關性研究. 臨床肺科雜志, 2022, 27(2): 222-225, 236.
27.	董建新, 楊華, 徐小琴, 等. 醫療衛生服務可及性的分析框架: 復雜性視角. 醫學與哲學, 2022, 43(16): 7-11.
28.	陳蘭馨, 李躍平. 醫療服務可及性對居民健康狀況的影響研究—基于CFPS數據的實證分析. 南京醫科大學學報(社會科學版), 2022, 22(3): 278-284.
29.	Aukst Margetic B, Kukulj S, Galic K, et al. Personality and stigma in lung cancer patients. Psychiatr Danub, 2020, 32(Suppl 4): 528-532.
30.	Marlow LAV, Waller J, Wardle J. Does lung cancer attract greater stigma than other cancer types? Lung Cancer, 2015, 88: 104–107.
31.	楊晶瑩, 劉科群, 章麗貞. 健康素養和社會支持對中青年首發腦卒中患者就醫延遲意向的影響分析. 實用預防醫學, 2023, 30(5): 607-610.
32.	葉慧. 追蹤護理模式在改善腫瘤患者就醫決策延遲中的應用研究. 甘肅科技, 2023, 39(2): 90-94.
33.	Cancino RS, Su Z, Mesa R, et al. The impact of COVID-19 on cancer screening: challenges and opportunities. JMIR Cancer, 2020, 6(2): e21697.
34.	Sha Z, Chang K, Mi J, et al. The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med, 2020, 9(5): 3373-3378.
35.	王子予, 韓茜宇, 郝艷華, 等. 新冠肺炎疫情下慢性病患者就醫延遲問題調查與分析. 中國醫院管理, 2022, 42(3): 43-47.
36.	Singh AP, Berman AT, Marmarelis ME, et al. Management of lung cancer during the COVID-19 pandemic. JCO Oncol Pract, 2020, 16(9): 579-586.
37.	赫捷, 李霓, 陳萬青, 等. 中國肺癌篩查與早診早治指南(2021, 北京). 中華腫瘤雜志, 2021, 43(3): 243-268.
38.	Peter J, Gerard A, Lesley H, et al. Screening for lung cancer CHEST guideline and expert panel report. Chest, 2021, 160(5): e427-e494.
39.	Haaf KT, Bastani M, Cao P, et al. A comparative modeling analysis of risk-based lung cancer screening strategies. J Natl Cancer Inst, 2020, 112(5): 466-479.
40.	王芬, 張綺珊, 孫興蘭, 等. 信息框架對居民腦卒中就醫延遲行為意向的影響研究. 中國全科醫學, 2023, 26(1): 64-73.
41.	Zhang J, IJzerman MJ, Oberoi J, et al. Time to diagnosis and treatment of lung cancer: a systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer, 2022, 166: 27-39.
42.	中國縣域醫院肺癌篩查共識編寫專家組, 中華醫學會呼吸分會肺癌學組. 中國縣域肺癌篩查共識(2020年). 中華醫學雜志, 2021, 101(14): 979-988.
43.	Maklouf-Quirós A, Simithy J, Ragoobar K, et al. Barriers to lung cancer referral, diagnosis, and treatment in Central America and the Caribbean: the health professionals' perspectives. Support Care Cancer, 2021, 29(2): 751-757.
44.	Somayaji D, Mohedat H, Dean GE, et al. Patients' perceptions at diagnosis: lung cancer discovery and provider relationships. Cancer Nurs, 2022, 45(5): 397-405.
45.	Saab MM, McCarthy M, O'Driscoll M, et al. A systematic review of interventions to recognise, refer and diagnose patients with lung cancer symptoms. NPJ Prim Care Respir Med, 2022, 32(1): 42.
46.	Patel S, Issaka RB, Chen E, et al. Colorectal cancer screening and COVID-19. Am J Gastroenterol, 2021, 116(2): 433-434.
47.	Varela-Centelles P, Seoane J, Bilbao A, et al. Covid-19 pandemic: a new contributing factor to diagnostic and treatment delay in oral cancer patients. Oral Oncol, 2021, 116: 105176.

1. Shankar A, Saini D, Dubey A, et al. Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward. Transl Lung Cancer Res, 2019, 8(Suppl 1): S106-S121.
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
3. Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ, 2020, 4(371): m4087.
4. 繆愛云. 我國癌癥病人就醫延遲現狀研究的文獻分析. 循證護理, 2021, 7(3): 382-385.
5. 余柳瑩. 350例肺癌患者首發癥狀與就診延遲相關性分析. 中國醫藥科學, 2021, 11(2): 187 -190.
6. Albano D, Bilfinger T, Feraca M, et al. A multidisciplinary lung cancer program: does it reduce delay between diagnosis and treatment? Lung, 2020, 198(6): 967-972.
7. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Thorac Oncol, 2016, 11(1): 39-51.
8. Borges M, Gouveia M, Alarc?o J, et al. Cost and burden of non-small cell lung cancer’s in Portugal. Value Health, 2014, 17(7): A626.
9. 林璜, William W. Au, 歐利民. 癌癥延遲就醫研究. 中國腫瘤, 2016, 25(9): 667-671.
10. Koo MM, Zhou Y, Lyratzopoulos G. Delays in diagnosis and treatment of lung cancer: Lessons from US healthcare settings. Cancer Epidemiol, 2015, 39(11): 45-47.
11. Vinas F, Ben Hassen I, Jabot L, et al. Delays for diagnosis and treatment of lung cancers: a systematic review. Clin Respir J, 2016, 10(2): 67-71.
12. González-Barcala FJ, García-Prim JM, Alvarez-Doba?o JM, et al. Effect of delays on survival in patients with lung cancer. Clin Transl Oncol, 2010, 12(8): 36-42.
13. Lubuzo B, Ginindza T, Hlongwana K. The barriers to initiating lung cancer care in low-and middle-income countries. Pan Afr Med J, 2020, 12: 35-38.
14. 鄒浩, 姜東旭, 張琳琳. 慢性病患者就醫延遲評估工具及影響因素的研究進展. 中國全科醫學, 2022, 25(7): 893-898.
15. Li PW, Lee DT, Yu DS. Psychometric evaluation of the perceived barriers to health care-seeking decision in Chinese patients with acute coronary syndromes. Heart Lung, 2014, 43(2): 140-145.
16. 楊柳青, 郝志紅. Fischer就醫態度量表的漢化及信效度分析. 中華行為醫學與腦科學雜志, 2020, 29(8): 757-762.
17. 王蕊琪, 賈紅紅, 周郁秋. 糖尿病診治延誤認知行為意向量表的開發與驗證. 中國全科醫學, 2021, 24(18): 2342-2348, 2358.
18. 趙秋利, 吳燕妮. 缺血性卒中高危者院前延遲行為意向測評量表的編制與驗證. 中國全科醫學, 2012, 15(32): 3703-3706, 3709.
19. Lubuzo B, Ginindza T, Hlongwana K. Exploring barriers to lung cancer patient access, diagnosis, referral and treatment in Kwazulu-Natal, South Africa: the health providers' perspectives. Transl Lung Cancer Res, 2019, 8(4): 380-391.
20. Mapanga W, Norris SA, Chen WC, et al. Consensus study on the health system and patient-related barriers for lung cancer management in South Africa. PLoS One, 2021, 16(2): e0246716.
21. Malalasekera A, Dhillon HM, Shunmugasundaram C, et al. Why do delays to diagnosis and treatment of lung cancer occur? A mixed methods study of insights from Australian clinicians. Asia Pac J Clin Oncol, 2021, 17(2): e77-e86.
22. van Os S, Syversen A, Whitaker KL, et al. Lung cancer symptom appraisal, help-seeking and diagnosis-rapid systematic review of differences between patients with and without a smoking history. Psychooncology, 2022, 31(4): 562-576.
23. 陳慶馀. 臺灣家庭醫學的發展與挑戰. 中國全科醫學, 2016, 19(4): 375-377.
24. Amadori D, Serra P, Bucchi L, et al. The mwanza cancer project. Lancet Oncol, 2016, 17(2): 146-148.
25. Barata F, Fidalgo P, Figueiredo S, et al. Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis. PLoS One, 2021, 16(6): e0252529.
26. 周敏, 許震娟. 慢阻肺急性加重期患者延遲就醫與家庭動力學的相關性研究. 臨床肺科雜志, 2022, 27(2): 222-225, 236.
27. 董建新, 楊華, 徐小琴, 等. 醫療衛生服務可及性的分析框架: 復雜性視角. 醫學與哲學, 2022, 43(16): 7-11.
28. 陳蘭馨, 李躍平. 醫療服務可及性對居民健康狀況的影響研究—基于CFPS數據的實證分析. 南京醫科大學學報(社會科學版), 2022, 22(3): 278-284.
29. Aukst Margetic B, Kukulj S, Galic K, et al. Personality and stigma in lung cancer patients. Psychiatr Danub, 2020, 32(Suppl 4): 528-532.
30. Marlow LAV, Waller J, Wardle J. Does lung cancer attract greater stigma than other cancer types? Lung Cancer, 2015, 88: 104–107.
31. 楊晶瑩, 劉科群, 章麗貞. 健康素養和社會支持對中青年首發腦卒中患者就醫延遲意向的影響分析. 實用預防醫學, 2023, 30(5): 607-610.
32. 葉慧. 追蹤護理模式在改善腫瘤患者就醫決策延遲中的應用研究. 甘肅科技, 2023, 39(2): 90-94.
33. Cancino RS, Su Z, Mesa R, et al. The impact of COVID-19 on cancer screening: challenges and opportunities. JMIR Cancer, 2020, 6(2): e21697.
34. Sha Z, Chang K, Mi J, et al. The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med, 2020, 9(5): 3373-3378.
35. 王子予, 韓茜宇, 郝艷華, 等. 新冠肺炎疫情下慢性病患者就醫延遲問題調查與分析. 中國醫院管理, 2022, 42(3): 43-47.
36. Singh AP, Berman AT, Marmarelis ME, et al. Management of lung cancer during the COVID-19 pandemic. JCO Oncol Pract, 2020, 16(9): 579-586.
37. 赫捷, 李霓, 陳萬青, 等. 中國肺癌篩查與早診早治指南(2021, 北京). 中華腫瘤雜志, 2021, 43(3): 243-268.
38. Peter J, Gerard A, Lesley H, et al. Screening for lung cancer CHEST guideline and expert panel report. Chest, 2021, 160(5): e427-e494.
39. Haaf KT, Bastani M, Cao P, et al. A comparative modeling analysis of risk-based lung cancer screening strategies. J Natl Cancer Inst, 2020, 112(5): 466-479.
40. 王芬, 張綺珊, 孫興蘭, 等. 信息框架對居民腦卒中就醫延遲行為意向的影響研究. 中國全科醫學, 2023, 26(1): 64-73.
41. Zhang J, IJzerman MJ, Oberoi J, et al. Time to diagnosis and treatment of lung cancer: a systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer, 2022, 166: 27-39.
42. 中國縣域醫院肺癌篩查共識編寫專家組, 中華醫學會呼吸分會肺癌學組. 中國縣域肺癌篩查共識(2020年). 中華醫學雜志, 2021, 101(14): 979-988.
43. Maklouf-Quirós A, Simithy J, Ragoobar K, et al. Barriers to lung cancer referral, diagnosis, and treatment in Central America and the Caribbean: the health professionals' perspectives. Support Care Cancer, 2021, 29(2): 751-757.
44. Somayaji D, Mohedat H, Dean GE, et al. Patients' perceptions at diagnosis: lung cancer discovery and provider relationships. Cancer Nurs, 2022, 45(5): 397-405.
45. Saab MM, McCarthy M, O'Driscoll M, et al. A systematic review of interventions to recognise, refer and diagnose patients with lung cancer symptoms. NPJ Prim Care Respir Med, 2022, 32(1): 42.
46. Patel S, Issaka RB, Chen E, et al. Colorectal cancer screening and COVID-19. Am J Gastroenterol, 2021, 116(2): 433-434.
47. Varela-Centelles P, Seoane J, Bilbao A, et al. Covid-19 pandemic: a new contributing factor to diagnostic and treatment delay in oral cancer patients. Oral Oncol, 2021, 116: 105176.

Previous Article
骨膜蛋白在特發性肺纖維化中的研究進展

Chinese Journal of Respiratory and Critical Care Medicine

肺癌患者就醫延遲影響因素及干預措施研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content